Treating Pregnant Women in the Cath Lab & Management of ACS-Myocardial Infarction in Pregnancy

Video Transcription

Video Summary

Dr. Nathaniel Smilowicz, an assistant professor in the Department of Medicine at the NYU Grossman School of Medicine and an interventional cardiologist at NYU, discussed myocardial infarction (M.I.) in pregnancy. He presented findings from a population-based study of 55 million pregnancy-related hospitalizations, which showed that the rate of M.I. during pregnancy increased over time. M.I. was found to be most common in the postpartum period. Although M.I. is more common in older pregnant women, it can also occur in younger women. Risk factors for M.I. in pregnancy include tobacco use, hypertension, hypopedemia, diabetes, and renal disease. However, a significant portion of M.I. cases occurred in women without established cardiovascular risk factors. The video also covered the management of M.I. in pregnancy, including medications that can be used safely and those that should be avoided, strategies for invasive management, and considerations for pregnant women undergoing angiography and PCI. Dr. Smilowicz emphasized the importance of interdisciplinary care between obstetrics and cardiovascular teams to improve outcomes.

Asset Subtitle

Nathaniel R. Smilowitz, MD, FSCAI

Keywords

myocardial infarction

pregnancy

M.I.

postpartum period

cardiovascular risk factors